Total Payments
$10,477
2024 Payments
$3,315
Companies
43
Transactions
676
Medicare Patients
5,866
Medicare Billing
$678,392
Payment Breakdown by Category
Food & Beverage$10,130 (96.7%)
Other$197.93 (1.9%)
Education$148.55 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,130 | 663 | 96.7% |
| Education | $148.55 | 6 | 1.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $119.41 | 6 | 1.1% |
| Honoraria | $78.52 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,236 | 151 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,026 | 66 | $0 (2024) |
| Amgen Inc. | $865.55 | 66 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $728.15 | 63 | $0 (2024) |
| MDD US Operations, LLC | $543.82 | 13 | $0 (2024) |
| Allergan, Inc. | $448.94 | 33 | $0 (2020) |
| GENZYME CORPORATION | $431.92 | 25 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $426.96 | 28 | $0 (2021) |
| Biogen, Inc. | $403.44 | 37 | $0 (2023) |
| Lilly USA, LLC | $322.27 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,315 | 162 | ABBVIE INC. ($884.83) |
| 2023 | $1,500 | 97 | AbbVie Inc. ($732.77) |
| 2022 | $588.99 | 35 | ABBVIE INC. ($290.95) |
| 2021 | $257.10 | 22 | AbbVie Inc. ($127.84) |
| 2020 | $242.94 | 15 | Amgen Inc. ($87.40) |
| 2019 | $419.81 | 36 | Amgen Inc. ($293.65) |
| 2018 | $2,025 | 146 | Amgen Inc. ($309.71) |
| 2017 | $2,128 | 163 | Teva Pharmaceuticals USA, Inc. ($404.00) |
All Payment Transactions
676 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Neurology | ||||||
| 11/27/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: Neurology | ||||||
| 11/25/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Neurology | ||||||
| 11/13/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Neurology | ||||||
| 11/10/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Neurology | ||||||
| 11/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.04 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Rare Disease | ||||||
| 10/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: PAIN | ||||||
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.01 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Neurology | ||||||
| 10/22/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Neuropsychiatry | ||||||
| 10/17/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Neuroscience | ||||||
| 10/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.82 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.82 | General |
| Category: Neuroscience | ||||||
| 10/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,408 | 14,464 | $652,832 | $172,244 |
| 2022 | 23 | 1,311 | 12,570 | $584,104 | $154,649 |
| 2021 | 27 | 1,539 | 16,455 | $690,747 | $187,250 |
| 2020 | 31 | 1,608 | 14,402 | $695,179 | $164,250 |
Total Patients
5,866
Total Services
57,891
Medicare Billing
$678,392
Procedure Codes
108
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 24 | 12,000 | $263,568 | $52,420 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 260 | 415 | $80,095 | $32,260 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 179 | 266 | $34,580 | $14,709 | 42.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 121 | 195 | $44,786 | $12,716 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 92 | 92 | $27,242 | $9,492 | 34.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 67 | 67 | $22,834 | $6,160 | 27.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 41 | 41 | $14,856 | $5,691 | 38.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 37 | 38 | $17,311 | $4,986 | 28.8% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 19 | 53 | $19,465 | $4,911 | 25.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 11 | 49 | $15,030 | $4,274 | 28.4% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 34 | 34 | $38,350 | $4,218 | 11.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 13 | 13 | $11,257 | $3,954 | 35.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 24 | 24 | $16,115 | $3,543 | 22.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 24 | $6,264 | $3,104 | 49.6% |
| 72156 | Mri scan of upper spinal canal before and after contrast | Office | 2023 | 14 | 14 | $10,969 | $1,607 | 14.6% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 11 | 11 | $5,846 | $1,236 | 21.1% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 15 | 15 | $4,832 | $1,178 | 24.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 113 | 150 | $1,239 | $1,161 | 93.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 77 | 97 | $2,910 | $997.05 | 34.3% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 12 | 12 | $8,127 | $952.23 | 11.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 75 | 107 | $2,204 | $803.62 | 36.5% |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | Office | 2023 | 38 | 640 | $1,920 | $678.49 | 35.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 29 | 29 | $1,181 | $477.34 | 40.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 29 | 29 | $1,050 | $428.62 | 40.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 13 | 13 | $351.00 | $123.76 | 35.3% |
About Dr. Christopher Wright, M.D
Dr. Christopher Wright, M.D is a Neurology healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902983026.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Wright, M.D has received a total of $10,477 in payments from pharmaceutical and medical device companies, with $3,315 received in 2024. These payments were reported across 676 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($10,130).
As a Medicare-enrolled provider, Wright has provided services to 5,866 Medicare beneficiaries, totaling 57,891 services with total Medicare billing of $678,392. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Little Rock, AR
- Active Since 11/01/2006
- Last Updated 04/17/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1902983026
Products in Payments
- UBRELVY (Drug) $816.19
- KESIMPTA (Drug) $746.41
- Aimovig (Biological) $743.70
- QULIPTA (Drug) $612.89
- BOTOX (Biological) $560.35
- COPAXONE (Drug) $459.74
- RYTARY (Drug) $438.56
- Gocovri (Drug) $405.52
- TROKENDI XR (Drug) $323.42
- Leqembi (Drug) $250.83
- APTIOM (Drug) $240.89
- NURTEC ODT (Drug) $219.32
- TECFIDERA (Drug) $201.69
- LEMTRADA (Drug) $194.72
- BOTOX THERAPEUTIC (Biological) $174.66
- TYSABRI (Biological) $167.86
- AUBAGIO (Drug) $166.49
- LYRICA (Drug) $164.93
- GILENYA (Drug) $143.32
- NAMZARIC (Drug) $138.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Little Rock
Dr. Shitiz Sriwastava, M.d, M.D
Neurology — Payments: $59,492
Neurology $59,492
John Ironside, M.d, M.D
Neurology — Payments: $46,574
Neurology $46,574
Elizabeth Sullivan, M. D, M. D
Neurology — Payments: $34,316
Neurology $34,316
Robert Silzer, M.d, M.D
Neurology — Payments: $14,084
Neurology $14,084
Bradley Boop, M.d, M.D
Neurology — Payments: $14,081
Neurology $14,081
Dr. Kapil Arya, M.d, M.D
Neurology — Payments: $13,409
Neurology $13,409